| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 4391 | 2018 |
| Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer L Derosa, MD Hellmann, M Spaziano, D Halpenny, M Fidelle, H Rizvi, ... Annals of Oncology 29 (6), 1437-1444, 2018 | 751 | 2018 |
| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ... Cell 182 (6), 1401-1418. e18, 2020 | 736 | 2020 |
| Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. M Pasquali, J Vela, R Kyle, T Leong, E Fritz, S Suciu, IP Palva, T Oivanen, ... Journal of Clinical Oncology 16 (12), 3832-3842, 1998 | 438 | 1998 |
| Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease K Mulder, AA Patel, WT Kong, C Piot, E Halitzki, G Dunsmore, ... Immunity 54 (8), 1883-1900. e5, 2021 | 284 | 2021 |
| The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients M Del Re, E Biasco, S Crucitta, L Derosa, E Rofi, C Orlandini, M Miccoli, ... European urology 71 (4), 680-687, 2017 | 266 | 2017 |
| Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer L Derosa, B Routy, AM Thomas, V Iebba, G Zalcman, S Friard, J Mazieres, ... Nature medicine 28 (2), 315-324, 2022 | 260 | 2022 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 250 | 2021 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 247 | 2020 |
| Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients L Derosa, B Routy, M Fidelle, V Iebba, L Alla, E Pasolli, N Segata, ... European urology 78 (2), 195-206, 2020 | 227 | 2020 |
| Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma KA Lee, AM Thomas, LA Bolte, JR Björk, LK de Ruijter, F Armanini, ... Nature medicine 28 (3), 535-544, 2022 | 190 | 2022 |
| The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non–small cell lung cancer T Hakozaki, C Richard, A Elkrief, Y Hosomi, M Benlaïfaoui, I Mimpen, ... Cancer Immunology Research 8 (10), 1243-1250, 2020 | 186 | 2020 |
| The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? A Elkrief, L Derosa, G Kroemer, L Zitvogel, B Routy Annals of Oncology 30 (10), 1572-1579, 2019 | 185 | 2019 |
| Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 173 | 2021 |
| Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center H Izzedine, B Escudier, C Lhomme, P Pautier, P Rouvier, V Gueutin, ... Medicine 93 (24), 333-339, 2014 | 164 | 2014 |
| Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib C Lolli, U Basso, L Derosa, E Scarpi, T Sava, M Santoni, SJ Crabb, ... Oncotarget 7 (34), 54564, 2016 | 153 | 2016 |
| Immune responses during COVID-19 infection C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, ... Oncoimmunology 9 (1), 1807836, 2020 | 151 | 2020 |
| Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer MP Roberti, S Yonekura, CPM Duong, M Picard, G Ferrere, M Tidjani Alou, ... Nature medicine 26 (6), 919-931, 2020 | 137 | 2020 |
| Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study JF Huang, J Shen, X Li, R Rengan, N Silvestris, M Wang, L Derosa, ... Annals of translational medicine 8 (7), 2020 | 135 | 2020 |
| Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers FX Danlos, C Grajeda-Iglesias, S Durand, A Sauvat, M Roumier, D Cantin, ... Cell Death & Disease 12 (3), 258, 2021 | 130 | 2021 |
